Monitor for any strategic shifts or pipeline prioritization under the new Chair, but no immediate catalyst expected from this board change alone.
Price Chart
How similar events traded
Executive Summary
Recursion Pharmaceuticals appointed Fred Hassan as Chair of the Board, effective October 31, 2026, replacing Rob Hershberg who remains on the board. Hassan brings decades of pharmaceutical industry experience, including leadership roles at Schering-Plough, Pharmacia, and Warburg Pincus, as well as board seats at BridgeBio Pharma and Amgen. The appointment is a routine leadership change with no immediate financial impact.
Key Facts
- Fred Hassan appointed Chair of Recursion's Board, effective October 31, 2026
- Rob Hershberg remains on the Board
- Hassan has over 40 years of pharmaceutical industry experience
- Hassan currently serves as Executive Chair of Norstella and Director at Warburg Pincus
- Hassan's public board memberships include Precigen and BridgeBio Pharma
Financial Impact
No financial figures disclosed; routine board leadership change
Risk Factors
- No material risks identified; leadership change is routine
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3393720 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 4, 2026 today | Institutional Cluster | $3.78 | awaiting T+5 | awaiting T+5 | $3.91 (+3.44%) |
Nov 3, 2026 1d ago | 144 | $3.86 | awaiting T+5 | awaiting T+5 | $3.91 (+1.43%) |
Nov 2, 2026 1d ago | 8-K | No price | awaiting T+5 | awaiting T+5 | No price |
Nov 2, 2026 1d ago | Press Release | $3.81 | awaiting T+5 | awaiting T+5 | $3.91 (+2.62%) |
Nov 2, 2026 1d ago | Press Release | $3.83 | awaiting T+5 | awaiting T+5 | $3.91 (+2.17%) |
Nov 2, 2026 1d ago | Press Release | $3.81 | awaiting T+5 | awaiting T+5 | $3.91 (+2.62%) |
Oct 15, 2026 19d ago | 424B5 | $3.47 $3.58 | ▼ −3.32% | ▼ −3.23% | $3.91 (−12.84%) |
Oct 15, 2026 20d ago | 8-K | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.91 (−6.01%) |
Oct 15, 2026 20d ago | Press Release | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.91 (−6.01%) |
Oct 15, 2026 20d ago | Press Release | $4.16 $3.58 | ▲ +13.94% | ▲ +12.93% | $3.91 (+6.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers